Msi Methylation Sciences

Developer of small molecule therapies for major depressive disorder (MDD)

placeSurrey, British Columbia, Canada calendar_todayFounded 2007 groups11 employees language methylationsciences.com

Investor mix

4 investors on record; lead investors include Inventages, Quark Venture.

Investor typeCountShare
Venture capital4100%
Coming soon